{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T18:19:12Z","timestamp":1719944352698},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","annalsofvascularsurgery.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.avsg.2016.10.063","type":"journal-article","created":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T08:46:46Z","timestamp":1489222006000},"page":"293-298","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PX-18 Protects Human Saphenous Vein Endothelial Cells under Arterial Blood Pressure"],"prefix":"10.1016","volume":"42","author":[{"given":"Koba","family":"Kupreishvili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Stooker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reindert W.","family":"Emmens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander B.A.","family":"Vonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica A.","family":"Sipkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemieke","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Eijsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul H.","family":"Quax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor W.M.","family":"van Hinsbergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.J.","family":"Krijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans W.M.","family":"Niessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2016.10.063_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.CIR.104.3.365","article-title":"Current concepts of the pathogenesis of the acute coronary syndromes","volume":"104","author":"Libby","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2016.10.063_bib2","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMp048238","article-title":"Prolonging patency\u2014choosing coronary bypass grafts","volume":"351","author":"Lytle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2016.10.063_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.bioeng.8.010506.105023","article-title":"Biomechanical considerations in the design of graft: the homeostasis hypothesis","volume":"8","author":"Kassab","year":"2006","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.avsg.2016.10.063_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1159\/000054091","article-title":"Early remodeling of saphenous vein grafts: proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow","volume":"37","author":"Kalra","year":"2000","journal-title":"J Vasc Res"},{"key":"10.1016\/j.avsg.2016.10.063_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1096\/fasebj.14.2.261","article-title":"Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases","volume":"14","author":"Mayr","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.avsg.2016.10.063_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1152\/ajpcell.00340.2009","article-title":"Cytoskeletal structure regulates endothelial cell immunogenicity independent of fluid shear stress","volume":"298","author":"Vartanian","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.avsg.2016.10.063_bib7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbrc.2009.09.020","article-title":"Mechanical stretch enhances IL-8 production in pulmonary microvascular endothelial cells","volume":"389","author":"Iwaki","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.avsg.2016.10.063_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/01.ATV.20.3.751","article-title":"Expression of secretory group IIA phospholipase A2 in relation to the presence of microbial agents, macrophage infiltrates, and transcripts of proinflammatory cytokines in human aortic tissues","volume":"20","author":"Menschikowski","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2016.10.063_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2362.2008.01933.x","article-title":"Secretory type II phospholipase A2 in culprit coronary lesions is associated with myocardial infarction","volume":"38","author":"Nijmeijer","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.avsg.2016.10.063_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/187152906777441830","article-title":"Inhibition of sPLA2-IIA, C-reactive protein or complement: new therapy for patients with acute myocardial infarction?","volume":"6","author":"Krijnen","year":"2006","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.avsg.2016.10.063_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2261-9-7","article-title":"A-002 (Varespladib), a phospholipase A2 inhibitor, reduces atherosclerosis in guinea pigs","volume":"9","author":"Leite","year":"2009","journal-title":"BMC Cardiavasc Disord"},{"key":"10.1016\/j.avsg.2016.10.063_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/FJC.0b013e318195bfbc","article-title":"Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-\/- mice","volume":"53","author":"Fraser","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.avsg.2016.10.063_bib13","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2016.10.063_bib14","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1152\/ajpheart.00887.2002","article-title":"Type II secretory phospholipase A2 binds to ischemic flip-flopped cardiomyocytes and subsequently induces cell death","volume":"285","author":"Nijmeijer","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.avsg.2016.10.063_bib15","doi-asserted-by":"crossref","unstructured":"Ockaili RA,Salloum F,Mehta CK et\u00a0al., PX-18 a novel inhibitor of type IIA secretory phospholipase A2 induces pre and post-conditioning against myocardial infarction in rabbits: a role of mitochondrial KATP channels, Circulation 2007;116:II_323.","DOI":"10.1161\/circ.116.suppl_16.II_323-a"},{"key":"10.1016\/j.avsg.2016.10.063_bib16","first-page":"S889","article-title":"Abstract 3929: daily therapy with the phospholipase A2 inhibitor, PX-18, improves the chronic inflammatory state in obese mice and reduces infarct size following ischemia\/reperfusion","volume":"120","author":"Varma","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2016.10.063_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10495-009-0350-x","article-title":"Inhibition of type 2A secretory phospholipase A2 reduces death of cardiomyocytes in acute myocardial infarction","volume":"14","author":"van Dijk","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.avsg.2016.10.063_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1067\/mtc.2001.111656","article-title":"Perivenous support reduces early changes in human vein grafts: studies in whole blood perfused human vein segments","volume":"121","author":"Stooker","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.avsg.2016.10.063_bib19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.yjmcc.2010.07.017","article-title":"Inhibition of Rho-ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase","volume":"49","author":"Krijnen","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.avsg.2016.10.063_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.hlc.2004.04.004","article-title":"Saphenous vein grafts: to use or not to use?","volume":"13","author":"Raja","year":"2004","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.avsg.2016.10.063_bib21","first-page":"992","article-title":"Changes in vein interstitium following distension for aortocoronary bypass","volume":"30","author":"Kennedy","year":"1989","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.avsg.2016.10.063_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1054-8807(03)00058-9","article-title":"Surgical sealant in the prevention of early vein graft injury in an ex\u00a0vivo model","volume":"12","author":"Stooker","year":"2003","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.avsg.2016.10.063_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1010-7940(01)01121-6","article-title":"Perivenous application of fibrin glue reduces early injury to the human saphenous vein graft wall in an ex\u00a0vivo model","volume":"21","author":"Stooker","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.avsg.2016.10.063_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0952-3278(91)90173-3","article-title":"Mechanism(s) of cytoprotective and anti-inflammatory activity of PGB1 oligomers: PGBx has potent anti-phospholipase A2 and anti-oxidant activity","volume":"43","author":"Franson","year":"1991","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.avsg.2016.10.063_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.plefa.2006.12.004","article-title":"Prostaglandin production in human coronary artery endothelial cells is modulated differentially by selective phospholipase A(2) inhibitors","volume":"76","author":"Rastogi","year":"2007","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.avsg.2016.10.063_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-5223(19)35785-X","article-title":"Graft disease in patients with coronary bypass grafting. Why does it start? Where do we stop?","volume":"92","author":"Grondin","year":"1986","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.avsg.2016.10.063_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-197807000-00001","article-title":"Postoperative changes in autologous vein grafts","volume":"188","author":"Fuchs","year":"1978","journal-title":"Ann Surg"},{"key":"10.1016\/j.avsg.2016.10.063_bib28","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0002-8703(05)80249-2","article-title":"Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments of veins","volume":"119","author":"Kalan","year":"1990","journal-title":"Am Heart J"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509617303783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509617303783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T23:45:08Z","timestamp":1658792708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509617303783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":28,"alternative-id":["S0890509617303783"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2016.10.063","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PX-18 Protects Human Saphenous Vein Endothelial Cells under Arterial Blood Pressure","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2016.10.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}